GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Cyclically Adjusted PS Ratio

Hindustan Bio Sciences (BOM:532041) Cyclically Adjusted PS Ratio : 4.03 (As of Jun. 06, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Cyclically Adjusted PS Ratio?

As of today (2024-06-06), Hindustan Bio Sciences's current share price is ₹8.30. Hindustan Bio Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹2.06. Hindustan Bio Sciences's Cyclically Adjusted PS Ratio for today is 4.03.

The historical rank and industry rank for Hindustan Bio Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

BOM:532041' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.56   Med: 1.7   Max: 6.12
Current: 4.03

During the past years, Hindustan Bio Sciences's highest Cyclically Adjusted PS Ratio was 6.12. The lowest was 0.56. And the median was 1.70.

BOM:532041's Cyclically Adjusted PS Ratio is ranked worse than
75.4% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.05 vs BOM:532041: 4.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Hindustan Bio Sciences's adjusted revenue per share data for the three months ended in Mar. 2024 was ₹0.380. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₹2.06 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Hindustan Bio Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Hindustan Bio Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Cyclically Adjusted PS Ratio Chart

Hindustan Bio Sciences Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.97 1.59 2.40 3.52

Hindustan Bio Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.57 2.40 2.56 4.09 3.52

Competitive Comparison of Hindustan Bio Sciences's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Hindustan Bio Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hindustan Bio Sciences's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hindustan Bio Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Hindustan Bio Sciences's Cyclically Adjusted PS Ratio falls into.



Hindustan Bio Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Hindustan Bio Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=8.30/2.06
=4.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hindustan Bio Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Hindustan Bio Sciences's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.38/153.0345*153.0345
=0.380

Current CPI (Mar. 2024) = 153.0345.

Hindustan Bio Sciences Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 0.330 91.425 0.552
201406 0.020 94.103 0.033
201409 0.351 96.780 0.555
201412 0.220 96.780 0.348
201503 0.155 97.163 0.244
201506 0.577 99.841 0.884
201509 0.477 101.753 0.717
201512 0.000 102.901 0.000
201603 0.235 102.518 0.351
201606 0.000 105.961 0.000
201609 0.340 105.961 0.491
201612 0.362 105.196 0.527
201703 0.301 105.196 0.438
201706 0.000 107.109 0.000
201709 0.071 109.021 0.100
201712 0.360 109.404 0.504
201803 0.574 109.786 0.800
201806 0.654 111.317 0.899
201809 1.265 115.142 1.681
201812 0.998 115.142 1.326
201903 0.468 118.202 0.606
201906 0.579 120.880 0.733
201909 0.137 123.175 0.170
201912 0.373 126.235 0.452
202003 1.167 124.705 1.432
202006 0.550 127.000 0.663
202009 0.333 130.118 0.392
202012 0.000 130.889 0.000
202103 0.164 131.771 0.190
202106 0.180 134.084 0.205
202109 0.000 135.847 0.000
202112 0.234 138.161 0.259
202203 -0.016 138.822 -0.018
202206 0.216 142.347 0.232
202209 0.000 144.661 0.000
202212 0.334 145.763 0.351
202303 0.367 146.865 0.382
202309 0.287 151.492 0.290
202312 0.326 152.924 0.326
202403 0.380 153.035 0.380

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Hindustan Bio Sciences  (BOM:532041) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Hindustan Bio Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Hindustan Bio Sciences (BOM:532041) Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034
Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines